We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
SynenTec to Take Over Roche Cellavista System
Product News

SynenTec to Take Over Roche Cellavista System

SynenTec to Take Over Roche Cellavista System
Product News

SynenTec to Take Over Roche Cellavista System


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "SynenTec to Take Over Roche Cellavista System"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Roche and SynenTec have announced that Roche will transfer its Cellavista business to SynenTec, the German company which is the original inventor of the Cellavista System.

This agreement was made as a result of the Roche Applied Science decision to focus its business, and guarantees future optimal support and development of the technology for its customers.

The Cellavista Imaging System for noninvasively measuring cell expansion uses brightfield and fluorescence detection with multiwell plates, chamber slides or RoboFlasks, for a broad range of cellular applications in cell line development, cellular research and drug discovery.

“It is very important that we ensure uninterrupted support for our customers. We have found the ideal match in SynenTec”, said Dan Zabrowski, Head of Roche Applied Science.

“This acquisition adds significant value for Cellavista customers by enabling them to directly discuss their requirements and needs with the developer of the system,” says Matthias Pirsch, CEO of SynenTec.

Over the last years, SynenTec collaborated with Roche in cell imaging, and was closely involved in the development, service and support of Cellavista Systems.

With the business transfer SynenTec will take on worldwide distribution of Cellavista Systems, as well as providing application support and service.

Roche will remain the primary contact partner for all support needs for Cellavista Systems delivered by Roche or Innovatis over a transition phase until SynenTec assumes full responsibility on June 01, 2013.

Advertisement